Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Change in Account Payables (2020 - 2022)

Beauty Health (SKIN) has disclosed Change in Account Payables for 3 consecutive years, with -$7.3 million as the latest value for Q4 2022.

  • On a quarterly basis, Change in Account Payables fell 139.42% to -$7.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was -$262000.0, a 102.49% decrease, with the full-year FY2022 number at -$262000.0, down 102.49% from a year prior.
  • Change in Account Payables was -$7.3 million for Q4 2022 at Beauty Health, down from -$616000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $18.6 million in Q4 2021 to a low of -$7.3 million in Q4 2022.
  • A 3-year average of $1.3 million and a median of -$1.6 million in 2022 define the central range for Change in Account Payables.
  • Biggest YoY gain for Change in Account Payables was 290.19% in 2022; the steepest drop was 186.86% in 2022.
  • Beauty Health's Change in Account Payables stood at $6.3 million in 2020, then soared by 195.39% to $18.6 million in 2021, then plummeted by 139.42% to -$7.3 million in 2022.
  • Per Business Quant, the three most recent readings for SKIN's Change in Account Payables are -$7.3 million (Q4 2022), -$616000.0 (Q3 2022), and $10.3 million (Q2 2022).